6-tert-Butyl 8-ethyl 6-azaspiro[3.4]octane-6,8-dicarboxylate

Catalog No. :
ACXTOF130
CAS No. :
2055841-96-6
Molecular Formula :
C15H25NO4
Molecular Weight :
283.37

IUPAC Name:6-(tert-butyl) 8-ethyl 6-azaspiro[3.4]octane-6,8-dicarboxylate

6-tert-Butyl 8-ethyl 6-azaspiro[3.4]octane-6,8-dicarboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$65.00Login to see priceIn stockInquiry
1g95%$183.00Login to see priceIn stockInquiry
5g95%$732.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-tert-Butyl 8-ethyl 6-azaspiro[3.4]octane-6,8-dicarboxylate
IUPAC Name6-(tert-butyl) 8-ethyl 6-azaspiro[3.4]octane-6,8-dicarboxylate
MDL No.MFCD30531320
Molecular FormulaC15H25NO4
Molecular Weight283.37
SMILESO=C(N(CC1C(OCC)=O)CC21CCC2)OC(C)(C)C
InChI KeyWRNDOFPOBRBTPW-UHFFFAOYSA-N
Synonym6-Azaspiro[3.4]octane-6,8-dicarboxylic acid, 6-(1,1-dimethylethyl) 8-ethyl ester;Ethyl 6-Boc-6-azaspiro[3.4]octane-8-carboxylate;6-tert-butyl 8-ethyl 6-azaspiro[3.4]octane-6,8-dicarboxylate - [B84589]
CAS No.2055841-96-6
PubChem CID127264203

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACXTOF130 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXTOF130 route product structure diagram
    ACXTOF1302055841-96-6 In Stock
Inquiry

2. ACXTOF130 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXTOF130 route product structure diagram
    ACXTOF1302055841-96-6 In Stock
Inquiry

Comments (0)